a randomized , double-blind , placebo controlled study to investigate the long-term effect of cyclospasmol ( cyclandelate ) on the abnormal permeability of the blood-retinal barrier was performed in 26 patients with insulin-dependent diabetes mellitus for at least 1 year and minimal retinopathy .
C0795734
cyclospasmol
C0010525
cyclandelate